Lotus Resources Limited has launched a fully underwritten pro-rata accelerated non-renounceable entitlement offer to raise approximately A$60 million before costs. Priced at A$0.22 per new share, the offer allows eligible shareholders to acquire one new share for each existing share held. Canaccord acts as the underwriter. Additionally, the company is issuing a prospectus to enable secondary offerings of convertible notes and detachable warrants, pending shareholder approval at an extraordinary general meeting set for August 2026.
Key Points
- Lotus Resources Limited (ASX:LOT) has commenced a fully underwritten pro-rata accelerated non-renounceable entitlement offer
- The offer price is A$0.22 per new share, with eligible shareholders entitled to one new share per existing share held
- The entitlement offer aims to raise around A$60 million before costs and is fully underwritten by Canaccord
- Secondary offerings of convertible notes and detachable warrants require shareholder approval at an extraordinary general meeting in August 2026
- The prospectus was lodged with ASIC on 23 July 2026, with new securities issuable up to thirteen months from that date
Entitlement Offer Structure and Pricing Details
Lotus Resources has structured its capital raising through a fully underwritten pro-rata accelerated non-renounceable entitlement offer. Eligible shareholders may subscribe for one new share for every share they currently hold at an issue price of A$0.22 per share. This approach enables existing shareholders to maintain their proportional ownership by fully participating, while also offering flexibility for those opting not to take up their full entitlement.
The offer targets raising approximately A$60 million before costs. Being fully underwritten by Canaccord provides the company with certainty of capital raising completion. The non-renounceable format simplifies the capital raise process and ensures equal opportunity for all eligible shareholders. The accelerated timetable reflects the company's intent to complete the raising efficiently while adhering to regulatory requirements.
Canaccord's Underwriting and Lead Manager Responsibilities
Canaccord has committed to fully underwrite the entitlement offer, guaranteeing completion regardless of shareholder take-up. Serving as underwriter, lead manager, and bookrunner, Canaccord is responsible for smooth offer execution and placement of all new securities. The underwriting agreement, detailed in Section 8.1 of the prospectus, outlines the underwriter's rights, obligations, and fees.
Notably, Canaccord’s underwriting role applies solely to the entitlement offer and excludes the secondary offerings of convertible notes and detachable warrants. This distinction clarifies that while the primary capital raise is secured through underwriting, the secondary offers carry separate terms and risk profiles.
Secondary Offerings: Convertible Notes and Detachable Warrants
In addition to the entitlement offer, Lotus Resources has issued a prospectus to facilitate secondary offerings comprising convertible notes and detachable warrants. These are documented under section 708A(11) of the Corporations Act and ASIC Corporations (Sale Offers That Do Not Need Disclosure) Instrument 2026/94, which permits the prospectus to remove trading restrictions on shares issued upon conversion or exercise.
Details of these secondary offers are found in Section 1.19 of the prospectus. Unlike the entitlement offer, these secondary offerings are not underwritten and involve different risk considerations. Shareholder approval for these offerings will be sought at an extraordinary general meeting scheduled for August 2026, reflecting their potential dilutive impact on existing shareholders.
Shareholder Approval for Secondary Offers Scheduled for August 2026
Lotus Resources will hold an extraordinary general meeting in August 2026 to obtain shareholder consent for the convertible note and detachable warrant offers. This is a mandatory governance step required before proceeding with the secondary offerings. The meeting allows shareholders to review the terms and vote on these capital management initiatives.
Section 1.15 of the prospectus provides comprehensive information on the meeting, including voting procedures, timing, and resolutions. The separation between the entitlement offer—which does not require shareholder approval—and the secondary offers—which do—reflects differing regulatory requirements for these capital raising activities.
Prospectus Lodgement and Securities Issuance Timeline
The prospectus was lodged with ASIC on 23 July 2026. Under the Corporations Act, securities cannot be issued based on this prospectus later than thirteen months from the lodgement date, setting a deadline of 23 August 2027. This timeframe accommodates completion of both the entitlement and secondary offers, including shareholder voting.
Prepared as a transaction-specific prospectus for continuously quoted securities and options under section 713 of the Corporations Act, the document assumes investors have access to the company’s ongoing disclosures and market information, thus requiring less comprehensive disclosure than an initial public offering prospectus.
Eligibility and Application Process for the Entitlement Offer
The entitlement offer is open to eligible shareholders, with eligibility determined by legal, regulatory criteria and company discretion. This discretionary approach ensures compliance while allowing flexibility to address specific circumstances.
Applications must be submitted using original personalised entitlement forms, detailed in Section 6 of the prospectus. These forms specify each shareholder’s entitlement based on their holdings at the record date and provide the mechanism for communicating investment decisions. Shareholders should carefully follow all instructions to ensure proper processing.
Restrictions on Prospectus Distribution in the United States
The prospectus restricts distribution within the United States, permitting release only to eligible institutional shareholders by the company. This limitation complies with U.S. securities laws to avoid registration requirements under federal securities regulations. It ensures retail investors in the U.S. are not exposed to unregistered securities.
This geographic restriction is a standard measure employed by Australian-listed companies during capital raises. Investors should be aware of these limitations and understand applicable regulations in their jurisdictions before investing.
Underwriter Liability Disclaimers and Limited Responsibility
The prospectus includes disclaimers limiting liability for Canaccord and its related parties (the Underwriter Parties). They have not authorised or caused the issue of the prospectus and disclaim all liability to the fullest extent permitted by law. They make no representations regarding the prospectus contents except references to the underwriter’s name.
The Underwriter Parties also disclaim any duty or liability concerning the company’s discretion in determining investor eligibility. This allocation of risk is standard in underwritten offerings, protecting the underwriter from liability related to eligibility decisions. Investors are advised to independently assess the information provided.
Potential Conflicts of Interest and Market-Making Activities by Underwriter
Canaccord may have provided or may provide financial or advisory services to Lotus Resources for customary fees. The Underwriter Parties may hold or trade the company’s securities and could act as market makers or principals in transactions involving these securities, including acquiring shares through the entitlement offer or derivatives.
Such activities may result in substantial holdings that must be disclosed under continuous disclosure rules. The prospectus clarifies that the underwriter does not recommend whether investors should participate and disclaims any fiduciary relationship with investors.
Investment Risks and Speculative Nature of Securities
The prospectus emphasizes that investing in the offered securities is speculative. Neither the company nor the underwriter guarantees future performance or returns beyond legal requirements. Section 3 details key risks affecting company performance and investment value, including operational, market, regulatory, and other material risks.
Investors are urged to read the entire prospectus carefully and consider their own investment objectives and financial circumstances. Consultation with professional advisers such as stockbrokers, solicitors, financial advisers, or accountants is recommended for those with questions regarding the offers.